Ispecimen Inc. · NASDAQ:ISPC
Ispecimen — Investor Presentation (August 2022)
29 slides from Ispecimen's investor presentation, Aug 4, 2022
Slide 1: Transforming Biospecimen Procurement: August 2022 Investor Presentation
CONNECT. INNOVATE. August 2022 Investor Presentation TRANSFORMING BIOSPECIMEN PROCUREMENT An online marketplace for human biospecimens
Slide 2: Forward-Looking Statements
This presentation may contain forward - looking statements within the meaning of Section 27 A of the Securities Act of 1933 , as amended, and Section 21 E of the Securities Exchange Act of 1934 , as amended . Such forward - looking statements are characterized by future or conditional verbs such as
Slide 3: Executive Management Team
Christopher Ianelli, MD, PhD | Chief Executive Officer, President, and Director Dr . Ianelli has been serving as our Chief Executive Officer, President, and Director since founding iSpecimen in July 2009 . Dr . Ianelli served as Chief Executive Officer of Abkine Pharmaceuticals, Inc . Dr . Ianelli s
Slide 4: Investor Highlights
Investor Highlights 4 >200 Healthcare Provider / Supplier Organizations >450 Customer Organizations 1. Early - stage opportunity with a first mover advantage 2. $3B - $4B global biospecimen market growing at 10 - 15% per year 1 3. Unique two - sided marketplace disrupting the biospecimen procurement
Slide 5: Our Vision
Accelerate scientific discovery via an online marketplace that empowers researchers to instantly search for and gain access to patients, biospecimens, and data across a global network of healthcare providers Our Vision 5
Slide 6: Human Biospecimens are Essential for Life Science R&D
Human Biospecimens are Essential for Life Science R&D Basic Research Biomarker Identification & Validation Drug Discovery & Development Diagnostics Discovery & Validation Biofluids Solid Tissue Stem & Immune Cells Plasma, Serum, Urine, Saliva Industry Academia Government 6 Lung, Breast, Colon, Brain
Slide 7: Large and Inefficient Biospecimen Market
10 - 15% Annual Growth Fueled by precision and regenerative medicine research 2 Disconnected Market Participants in Need of a Marketplace Solution With an Inefficient Supply Chain Manual processes plus fragmentation make it ripe for an online marketplace solution Large and Inefficient Biospecimen Ma
Slide 8: Market Inefficiencies
Market Inefficiencies PROVIDER RESEARCHER Scientist / Informaticist Procurem ent Legal & Compliance IT / Informaticist Scientist & Informaticist Legal & Compliance IT / Informaticist Researcher & Procurement Legal & Compliance Principal Investigator & Specimen Operations PATIENTS PROVIDERS RESEARCHE
Slide 9: Inefficiencies Lead to Losses
Inefficiencies Lead to Losses Providers miss revenue and research opportunities > 3 Billion clinical specimens are discarded annually worldwide 5 > 1 Billion Patient encounters yearly in the U.S. where a specimen could be provided for research 4 > 800 Million banked specimens are in biorepository in
Slide 10: The iSpecimen Marketplace Solution
The iSpecimen Marketplace ® Solution 10 PROVIDER Procurement Principal Investigator / Operations IT / Informaticist PATIENTS Legal & Compliance IT / Informaticist Researcher & Procurement Legal & Compliance Principal Investigator & Specimen Operations Scientist & Informaticist Blood / Pheresi s Cent
Slide 11: Full-Service Procurement
Full - Service Procurement We Not Only Connect Suppliers and Customers, but Also Manage the Entire Procurement Process SPECIMEN SEARCH & SELECTION SPECIMEN LOGISTICS SPECIMEN MANAGEMENT DATA MANAGEMENT STUDY/ORDER MANAGEMENT SUPPLIER SITE TRAINING COLLECTION KIT BUILDING COMPLIANCE MANAGEMENT STUDY
Slide 12: Suppliers and Researchers Benefit
Suppliers and Researchers Benefit Advance Discovery Suppor t research mission and advance diagnostic, therapeutic, and vaccine research Increase Revenue Instantly connect to a global network of researchers Ensure Compliance On a platform that protects the privacy and security of patient information
Slide 13: Growing Supplier Adoption
13 34 66 102 147 181 200 214 2015 2016 2017 2018 2019 2020 2021 30-Jun-22 Growing Supplier Adoption 1000+ Hospitals Also includes two Healthcare Information Exchanges 54% CAGR Number of Suppliers (2015 – June 30, 2022) WORLDWIDE COVERAGE United States United Kingdom Germany France Ukraine Georgia Bu
Slide 14: Growing Researcher Adoption
$700 $1,448 $3,067 $4,395 $4,298 $8,184 $11,135 $4,857 2015 2016 2017 2018 2019 2020 2021 30-Jun-22 Cumulative Customer Organizations with Purchases 2015 – June 30, 2022 57% CAGR Customers (2015 – June 30, 2022) Annual Revenue ($000) - Unaudited 2015 - 18, 2022 2015 – June 30, 2022 59% CAGR Revenue
Slide 15: Growing Marketplace Adoption
80 118 668 1,587 2,681 3,871 5,218 5,995 2015 2016 2017 2018 2019 2020 2021 30-Jun-22 Cumulative Researcher and Supplier Marketplace Users 2015 – June 30, 2022 94% CAGR Registered Users (2015 – June 30, 2022) Growing Marketplace Adoption ~4,400 Unique searches performed by researchers in the iSpecim
Slide 16: Growing Data Asset
“Utilization of sample data for research and for monetization is the next key value driver for the biobanks.” - Frost & Sullivan, Global Biobanking Market Landscape Growing Data Asset Banked Specimen Records Patient Records Medical Condition Records Clinical Specimen Records Laboratory Test Records
Slide 17: Statements of Operations (Unaudited)
Statements of Operations (Unaudited) 17 Revenue $ 2,338,688 $ 2,903,876 $ 4,857,348 $ 5,867,683 Operating Expenses: Revenue (Q2 2022 vs. Q2 2022) Cost of revenue 999,743 1,489,196 2,165,659 3,112,847 Technology 635,650 361,799 1,163,173 771,750 $2.9M Sales and marketing 950,563 647,592 1,697,994 1,1
Slide 18: Balance Sheets
Balance Sheets 18 June 30, 2022 December 31, 2021 (Unaudited) Assets Cash 23,691,175$ 27,738,979$ Accounts receivable - unbilled 1,264,278 1,739,020 Accounts receivable, net of allowance 1,660,076 3,002,442 Prepaid expenses and other current assets 374,867 327,035 Tax credit receivable, net of curre
Slide 19: Fully Diluted Shares of Common Stock Outstanding
Fully Diluted Shares of Common Stock Outstanding 19 Diluted Shares of Common Stock Shares outstanding at June 30, 2022 8,873,711 Shares issuable upon vesting of restricted stock units 367,118 Shares issuable upon exercise of stock options 171,154 Shares issuable upon exercise of PIPE Warrant to purc
Slide 20: Investor Summary
Investor Summary 20 >200 Healthcare Provider / Supplier Organizations >450 Customer Organizations 1. Early - stage opportunity with a first mover advantage 2. $3B - $4B global biospecimen market growing at 10 - 15% per year 3. Unique two - sided marketplace disrupting the biospecimen procurement pro
Slide 21: Contact Us
CONNECT. INNOVATE. Sign up for free iSpecimen Marketplace account at www.ispecimen.com CONTACT US iSpecimen Inc. 450 Bedford Street Lexington, MA 02420 investors@ispecimen.com ispecimen.com
Slide 22: Appendix
Appendix 22
Slide 23: Strategic Evolution
Strategic Evolution PHASE 3 Expansion via the Online iSpecimen Marketplace Ƞ START UP Company Ideation and Self - Funding PHASE 1 Proof of Concept PHASE 2 Critical Mass of Suppliers and Early Customer Adoption 2010 – 2011 2012 – 2013 2014 – 2017 2018 – June 30, 2022 0 Customers 1 Supplier Agreement
Slide 24: iSpecimen Marketplace UI/UX
iSpecimen Marketplace UI/UX Click Search to start searching for specimens 24
Slide 25: iSpecimen Marketplace UI/UX
25 iSpecimen Marketplace UI/UX Use search bar to quickly find specimens that match search criteria
Slide 26: Refine Search Results Using Sliders and Check Boxes
Refine Search Results Using Sliders and Check Boxes iSpecimen Marketplace UI/UX 26
Slide 27: View Quote Request and Add More Specimens
View Quote Request and Add More Specimens Request a Quote iSpecimen Marketplace UI/UX 27 Track and Manage Requests
Slide 28: Sources Cited
28 Page Note Source Cited 7 1 iSpecimen estimates based on In Vitro Diagnostics Market Size, Share & Trends Analysis Report By Product, By Application, By Technology (Immunochemistry, Molecular Diagnostics) By End - use, By Region, And Segment Forecasts, 2021 – 2027. Grandview Research, January 2021
Slide 29: iSpecimen Marketplace
@ iSPECIMEN Marketplace’